MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with R

Ribavirin

Ribavirin 200mg capsules

Use with caution

Stability notes for Ribavirin 200mg capsules

Protect from light and store in airtight containers. Freely soluble in water.

Provenance

This compatibility recommendation is derived from Ribavirin 200mg capsules (Milpharm Ltd).

Supplier

Ribavirin 200mg capsules (Milpharm Ltd)

Ribavirin 200mg tablets

Use with caution

Stability notes for Ribavirin 200mg tablets

Store in airtight containers and protect from moisture.

Provenance

This compatibility recommendation is derived from Ribavirin 200mg tablets (Milpharm Ltd).

Supplier

Ribavirin 200mg tablets (Milpharm Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.